Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Immunotherapy
|
May 4, 2023
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, et al.
Metabolism: Clinical and Experimental
|
May 25, 2025
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response
Guo-Qiang Pan, Yu-Chuan Yan, Rui-Zhe Li, et al.
Expert Review of Gastroenterology & Hepatology
|
May 6, 2023
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
Hui Liu, Cheng-Long Han, Bao-Wen Tian, et al.
Food & Function
|
April 22, 2025
An umbrella review of the association between dietary factors and hepatocellular carcinoma risk
Han Li, Qi-Hang Cao, Hui Liu, et al.
Cancer Immunology, Immunotherapy : CII
|
February 22, 2023
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
The Oncologist
|
June 28, 2024
Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis
Shi-Jia Liu, Lun-Jie Yan, Han-Chao Wang, et al.
Clinical & Experimental Metastasis
|
June 12, 2023
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis
Bao-Wen Tian, Cheng-Long Han, Han-Chao Wang, et al.
JHEP Reports : Innovation in Hepatology
|
October 20, 2025
A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinoma
Qi-Hang Cao, Han Li, Peng-Fei Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
Xiao-Feng Dong, Tian-Qi Liu, Xu-Ting Zhi, et al.
Journal of Gastroenterology and Hepatology
|
April 30, 2024
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis
Qi-Hang Cao, Hui Liu, Lun-Jie Yan, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Immunotherapy
|
May 4, 2023
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, et al.
Metabolism: Clinical and Experimental
|
May 25, 2025
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response
Guo-Qiang Pan, Yu-Chuan Yan, Rui-Zhe Li, et al.
Expert Review of Gastroenterology & Hepatology
|
May 6, 2023
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
Hui Liu, Cheng-Long Han, Bao-Wen Tian, et al.
Food & Function
|
April 22, 2025
An umbrella review of the association between dietary factors and hepatocellular carcinoma risk
Han Li, Qi-Hang Cao, Hui Liu, et al.
Cancer Immunology, Immunotherapy : CII
|
February 22, 2023
Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, et al.
The Oncologist
|
June 28, 2024
Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis
Shi-Jia Liu, Lun-Jie Yan, Han-Chao Wang, et al.
Clinical & Experimental Metastasis
|
June 12, 2023
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis
Bao-Wen Tian, Cheng-Long Han, Han-Chao Wang, et al.
JHEP Reports : Innovation in Hepatology
|
October 20, 2025
A pathomics-integrated multimodal model to evaluate chemoimmunotherapy efficacy in unresectable intrahepatic cholangiocarcinoma
Qi-Hang Cao, Han Li, Peng-Fei Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment
Xiao-Feng Dong, Tian-Qi Liu, Xu-Ting Zhi, et al.
Journal of Gastroenterology and Hepatology
|
April 30, 2024
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis
Qi-Hang Cao, Hui Liu, Lun-Jie Yan, et al.
Page
of 8